Cell Sorters

Global Cell Sorters Market to Reach US$891.1 Million by 2030

The global market for Cell Sorters estimated at US$572.1 Million in the year 2024, is expected to reach US$891.1 Million by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$630.5 Million by the end of the analysis period. Growth in the Consumables & Reagents segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$155.9 Million While China is Forecast to Grow at 12.2% CAGR

The Cell Sorters market in the U.S. is estimated at US$155.9 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$191.6 Million by the year 2030 trailing a CAGR of 12.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.8% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Cell Sorters Market – Key Trends & Drivers Summarized

Why Are Cell Sorters Gaining Strategic Importance in High-Precision Cell Analysis and Therapeutic Development?
Cell sorters are becoming indispensable in biomedical research and clinical diagnostics as demand rises for high-purity, functionally intact cell populations across applications in immunology, oncology, stem cell research, and regenerative medicine. These instruments enable real-time separation of heterogeneous cell mixtures based on size, granularity, fluorescence markers, and surface antigens—offering unparalleled precision in isolating target cell subpopulations for downstream applications such as single-cell genomics, cell therapy, and drug screening.

As workflows increasingly demand greater specificity and viability in sorted cells, especially in areas such as CAR-T cell development and circulating tumor cell (CTC) isolation, cell sorting technologies are evolving into essential tools for translational research and advanced therapeutics. Their ability to integrate sorting with phenotypic and functional characterization is positioning them as critical enablers of next-generation biomedical innovation.

How Are Technological Advancements Enhancing Throughput, Sensitivity, and Application Versatility in Cell Sorters?
Modern cell sorters are leveraging advancements in optics, microfluidics, and automation to deliver greater accuracy, speed, and ease of use. High-speed fluorescence-activated cell sorting (FACS) systems are now equipped with multicolor laser configurations, advanced droplet control systems, and real-time image-based detection to handle increasingly complex cell phenotyping requirements. These improvements are enabling the isolation of ultra-rare cell types and minimal residual disease (MRD) detection with enhanced sensitivity and reproducibility.

Innovations such as microfluidic chip-based sorters, closed-system sterile sorting for clinical-grade applications, and sorter-integrated single-cell dispensers are expanding use cases in clinical research and cell manufacturing. AI-enabled gating algorithms and user-friendly software interfaces are also improving data interpretation, throughput, and reproducibility, reducing the reliance on highly specialized operators and accelerating workflow standardization in core labs and hospital-based research centers.

Where Is Demand for Cell Sorters Accelerating and Which Segments Are Leading Adoption?
North America and Europe lead global demand, driven by strong investments in life sciences R&D, established academic and clinical research infrastructure, and active pipelines in cell and gene therapy. The U.S., Germany, and the U.K. represent key markets, supported by the presence of major research institutes, biopharma hubs, and public funding programs. Asia-Pacific is emerging as a growth engine—particularly in China, Japan, South Korea, and India—where expanding research capacity and growing participation in cell-based therapy development are driving adoption.

Key end-users include academic research institutions, biopharmaceutical companies, contract research organizations (CROs), and clinical laboratories focused on translational medicine, immunophenotyping, and hematologic malignancy analysis. Cell therapy developers and GMP-compliant manufacturing centers are increasingly investing in sterile, high-throughput sorters to meet regulatory and scalability requirements in personalized medicine workflows.

What Is Fueling the Global Growth of the Cell Sorters Market?
The global cell sorters market is expanding on the strength of rising demand for single-cell analysis, rapid advances in cellular therapies, and the increasing complexity of immunological and oncology research. The ability to isolate rare, functional, or engineered cells with high purity is central to innovation in diagnostics, therapeutics, and basic research. As personalized medicine, precision oncology, and stem cell applications scale globally, cell sorting systems are becoming vital for upstream quality control and cell population characterization.

Strategic collaborations between instrument manufacturers, biotech companies, and academic consortia are fostering product innovation and workflow integration. Additionally, rising demand for closed-system, GMP-compliant sorters is supporting the clinical translation of cell sorting technologies. As precision, sterility, and scalability become defining needs, a key question shapes the market`s future: Can cell sorter technologies continue to evolve toward higher resolution, automation, and regulatory readiness—while supporting the expanding role of cellular insights in research, diagnostics, and therapeutics?

SCOPE OF STUDY:

The report analyzes the Cell Sorters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Instruments, Consumables & Reagents); Application (Research Application, Clinical Applications); End-User (Hospitals & Clinical Testing Laboratories, Pharma & Biotech Companies, Other End-Users)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Affymetrix Inc. (Thermo Fisher Scientific)
• Beckman Coulter Inc. (Danaher Corporation)
• Becton, Dickinson and Company
• Bio-Rad Laboratories Inc.
• Bulldog Bio Inc.
• Cell Microsystems Inc.
• Cytonome/ST LLC
• Danaher Corporation
• Miltenyi Biotec GmbH
• Molecular Devices LLC
• Namocell Inc.
• NanoCellect Biomedical Inc.
• On-Chip Biotechnologies Co. Ltd.
• Sartorius AG
• Sony Biotechnology Inc.
• Standard BioTools Inc.
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• uFluidix
• Union Biometrica Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.